Pertuzumab 420mg
In stock
Description
Hertumab (Pertuzumab) 420mg Injection isa targeted therapy, specifically a recombinant humanized monoclonal antibody, designed to treat HER2-positive breast cancer. It acts as an HER2 receptor antagonist by binding to the extracellular domain II of the human epidermal growth factor receptor 2 protein (HER2), inhibiting ligand-dependent HER2-HER3 dimerization, which slows or stops cancer cell growth.

